GenomesDAO

Overview

GenomesDAO, spearheaded by Genomes.io (founded 2018, London), is a biotech DAO focused on the safe, private, and auditable monetization of genomic data. The platform combines AMD's SEV-ES encrypted virtualization, blockchain, and DeFi to give individuals full ownership and control over their DNA data.

GenomesDAO secured a new investment round led by Pantera Capital and Modular Capital in June 2024, validating the growing intersection of genomic data and decentralized infrastructure.

How It Works

GenomesDAO works with trusted, industry-leading DNA sequencing providers to deliver clinical quality (30x) whole genome sequencing that analyses 100% of the genome. User DNA data is stored in fully encrypted "DNA Vaults" using AMD SEV-ES technology, ensuring that only the user controls access.

Pharmaceutical companies and research organizations can query genomic data using GENOME tokens, with Genomes.io acting as a broker. Critically, users must approve each individual query of their vault — each query asks a specific question of the genome and only the answer to that question is released, preserving privacy while enabling research.

External Links

• Genomes.io — Official Website
• GenomesDAO Documentation
• GenomesDAO on X